Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy

Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy

Objective: Evaluate the real-world accuracy of Myxovirus resistance protein A (MxA) detected by the rapid, point-of-care FebriDx test during the second-wave pandemic in Italy in patients with acute respiratory infection (ARI) and a clinical suspicion of COVID-19. Design and methods: Prospective, obs...

Full description

Bibliographic Details
Main Authors: Filippo Lagi, Sasha Trevisan, Matteo Piccica, Lucia Graziani, Gregorio Basile, Jessica Mencarini, Beatrice Borchi, Lorenzo Menicacci, Micol Vaudo, Valentina Scotti, Alessia Fabbri, Giulia Bandini, Camilla Tozzetti, Andrea Berni, Noemi Aiezza, Giulia Pestelli, Valerio Turchi, Alberto Moggi Pignone, Loredana Poggesi, Carlo Nozzoli, Alessandro Morettini, Gian Maria Rossolini, Alessandro Bartoloni
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:International Journal of Infectious Diseases
Subjects:
COVID-19
FebriDx
Point-of-care
Italy
Accuracy
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971221003775

Internet

http://www.sciencedirect.com/science/article/pii/S1201971221003775

Similar Items